SPY413.22+0.36 0.09%
DIA338.69+1.90 0.56%
IXIC13,965.06-31.04 -0.22%

CTI BioPharma: Commercialization Activities on Track to Support Potential Approval and Launch of Pacritinib in U.S. in 2021 >CTIC

CTI BioPharma: Commercialization Activities on Track to Support Potential Approval and Launch of Pacritinib in U.S. in 2021 >CTIC

· 03/17/2021 16:08

Please log in to view news